Syndax Pharmaceuticals In... (SNDX)
undefined
undefined%
At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11
Revenue - - 139.71M 1.52M 1.52M 1.52M 2.11M 1.22M 627.00K - - - -
Cost of Revenue 12.00K 454.00K 456.00K - - - - - - - - - 51.00K
Gross Profit -12.00K -454.00K 139.25M 1.52M 1.52M 1.52M 2.11M 1.22M 627.00K - - - -51.00K
Operating Income -229.95M -151.76M 26.22M -71.42M -57.54M -75.88M -61.95M -43.77M -20.51M -21.33M -8.57M -8.73M -9.62M
Interest Income 21.16M 5.87M 403.00K 841.00K 1.57M - - - 161.00K - - - -
Pretax Income -209.36M -149.34M 24.93M -73.16M -56.05M -73.96M -60.80M -44.47M -24.12M -19.83M -14.17M -9.96M -13.09M
Net Income -209.36M -143.75M 24.93M -73.07M -55.95M -73.96M -60.80M -44.47M -24.12M -19.83M -14.17M -9.96M -13.09M
Selling & General & Admin 66.92M 33.26M 25.24M 22.50M 16.06M 17.29M 15.86M 13.32M 11.59M 11.16M 5.36M 3.49M 3.48M
Research & Development 163.03M 118.50M 88.25M 50.44M 42.99M 60.11M 48.20M 31.66M 9.55M 10.18M 3.21M 5.24M 6.09M
Other Expenses - 2.42M -1.29M -1.74M 1.49M 1.92M 1.15M -706.00K -37.00K 4.00K -3.01M -1K -
Operating Expenses 229.95M 151.76M 113.49M 72.94M 59.06M 77.39M 64.06M 44.99M 21.14M 21.33M 8.57M 8.73M 9.57M
Interest Expense 208.00K 3.14M 1.90M 2.36M 1.57M 1.94M 1.42M 956.00K 1.57M - - - 1.99M
Selling & Marketing Expenses - - - - - - - - - - - - -
Cost & Expenses 229.95M 151.76M 113.49M 72.94M 59.06M 77.39M 64.06M 44.99M 21.14M 21.33M 8.57M 8.73M 9.62M
Income Tax - -5.59M -43.00K -89.00K -92.00K 1.92M -76.00K -89.00K 1.54M -1.50M 2.59M 1.23M -
Shares Outstanding (Basic) 70.37M 60.76M 52.06M 41.31M 30.49M 25.37M 21.00M 14.62M 17.37M 9.60M 8.01M 70.28M 619.96K
Shares Outstanding (Diluted) 70.37M 60.76M 53.62M 41.31M 30.49M 25.37M 21.00M 14.62M 17.37M 9.60M 8.01M 70.28M 619.96K
EPS (Basic) -2.98 -2.37 0.48 -1.77 -1.84 -2.92 -2.9 -3.04 -1.39 -2.07 -1.77 -0.14 -21.11
EPS (Diluted) -2.98 -2.37 0.46 -1.77 -1.84 -2.92 -2.9 -3.04 -1.39 -2.07 -1.77 -0.14 -21.11
EBITDA -229.94M -151.76M 27.28M -70.29M -55.60M -73.88M -61.88M -43.68M -20.49M -21.32M -8.56M -5.26M -11.05M
Depreciation & Amortization 12.00K 454.00K 456.00K 515.00K 451.00K 78.00K 76.00K 89.00K 21.00K 15.00K 13.00K 34.00K 51.00K